Mass spectrometric quantification of endogenous beta-endorphin.

Area of Science:

• Biochemistry
• Endocrinology
• Analytical Chemistry

Background:

• Beta-endorphin (BE) is a key endogenous opioid peptide involved in pain modulation and stress response.
• Accurate quantification of BE in human tissues is crucial for understanding its physiological roles.

Purpose of the Study:

• To develop and validate sensitive mass spectrometry-based methods for quantifying endogenous beta-endorphin (BE) in individual human pituitary extracts.
• To compare quantification results obtained using two different mass spectrometric approaches.

Main Methods:

• Utilized fast atom bombardment (FAB) mass spectrometry and multiple reaction monitoring (MRM) with B/E linked-field scan.
• Employed stable isotope-labeled internal standards ((2H4-Ile22)BE1-31, human) for accurate quantification.
• Purified BE using Sep-Pak chromatography and HPLC, followed by trypsin digestion and analysis of the BE20-24 (NAIIK) fragment.

Main Results:

• Achieved linear calibration curves for BE quantification across a range of concentrations.
• Quantified endogenous BE in human pituitary extracts using both [M + H]+ ion analysis and MRM transitions.
• Reported mean BE levels of 156 +/- 84 pmol mg-1 protein (M + H]+ method) and 169 +/- 99 pmol mg-1 protein (MRM method).

Conclusions:

• Established reliable mass spectrometry-based methods for quantifying human pituitary beta-endorphin.
• Demonstrated the feasibility of measuring endogenous BE in individual human pituitary samples.
• Provided quantitative data on BE levels in the human pituitary, contributing to opioid peptide research.